FDA issues warnings to duodenoscope makers linked to infection outbreaks
BMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4544 (Published 20 August 2015) Cite this as: BMJ 2015;351:h4544- Michael McCarthy
- 1Seattle
The US Food and Drug Administration has sent warning letters1 to three makers of duodenoscopes whose devices have been linked to outbreaks of multidrug resistant strains of carbapenem resistant enterobacteriaceae. The three firms are Olympus Medical Systems, Fujifilm, and the Pentax division of Hoya.
The letters fault two of the manufacturers for failing to alert the FDA promptly after they learnt that patients had developed infections after undergoing endoscopic procedures with their devices, in one case waiting three years to file the required report. Under federal rules …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.